NASDAQ : VRDN
Viridian Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 24.8 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.81B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Viridian Therapeutics, Inc. (VRDN) reported revenue of 71.13M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 71.13M | 70.85M | 302.00K | 314.00K | 1.77M | 2.96M |
| Cost of Revenue | 324.68M | 338.93M | 238.25M | 159.76M | 100.89M | 56.89M |
| Gross Profit | -253.55M | -268.08M | -237.95M | -159.45M | -99.12M | -53.92M |
| Selling, General & Admin | 151.65M | 95.31M | 61.08M | 95.00M | 35.18M | 25.80M |
| Operating Expenses | 151.65M | 95.31M | 61.08M | 95.00M | 35.18M | 25.80M |
| Operating Income | -405.20M | -363.39M | -299.04M | -254.45M | -134.30M | -79.73M |
| Interest Expense | -15.62M | -4.95M | -2.20M | -1.33M | -486.00K | -3.00K |
| Interest & Investment Income | 29.68M | 27.40M | 31.60M | 18.24M | 4.92M | 318.00K |
| Other Non Operating Income (Expenses) | 4.17M | -1.66M | -314.00K | -193.00K | ||
| EBT Excluding Unusual Items | -386.97M | -342.60M | -269.95M | -237.73M | -129.87M | -79.41M |
| Pretax Income | -386.97M | -342.60M | -269.95M | -237.73M | -129.87M | -79.41M |
| Net Income | -386.97M | -342.60M | -269.95M | -237.73M | -129.87M | -79.41M |
| Preferred Dividends & Other Adjustments | -52.94M | -60.67M | -61.39M | -62.73M | -42.83M | |
| Net Income to Common | -334.03M | -281.93M | -208.56M | -175.01M | -87.04M | -79.41M |
| Shares Outstanding (Basic) | 96.60M | 84.80M | 67.89M | 44.76M | 32.09M | 11.92M |
| Shares Outstanding (Diluted) | 96.60M | 84.80M | 67.89M | 44.76M | 32.09M | 11.92M |
| EPS (Basic) | -3.46 | -3.32 | -3.07 | -3.91 | -2.71 | -6.66 |
| EPS (Diluted) | -3.46 | -3.32 | -3.07 | -3.91 | -2.71 | -6.66 |
| Free Cash Flow | -335.04M | -276.89M | -232.83M | -185.07M | -94.64M | -54.92M |
| Free Cash Flow Per Share | -3.47 | -3.27 | -3.43 | -4.13 | -2.95 | -4.61 |
| Operating Margin | -569.68% | -512.91% | -99,018.21% | -81,035.03% | -7,579.23% | -2,690.79% |
| Profit Margin | -469.63% | -397.93% | -69,059.60% | -55,734.71% | -4,912.13% | -2,680.15% |
| Free Cash Flow Margin | -471.04% | -390.81% | -77,096.03% | -58,938.85% | -5,340.58% | -1,853.49% |
| EBITDA | -404.73M | -362.94M | -298.50M | -253.93M | -134.05M | -79.61M |
| D&A For EBITDA | 468.00K | 460.00K | 540.00K | 522.00K | 255.00K | 120.00K |
| EBIT | -405.20M | -363.39M | -299.04M | -254.45M | -134.30M | -79.73M |
| Revenue as Reported | 71.13M | 70.85M | 302.00K | 314.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 164.99M | 212.38M | 99.59M | 102.83M | 155.58M | 42.30M |
| Short-Term Investments | 816.54M | 662.27M | 617.99M | 374.54M | 268.97M | 154.67M |
| Cash & Short-Term Investments | 981.53M | 874.65M | 717.58M | 477.37M | 424.55M | 196.97M |
| Receivables | 75.00M | 102.00K | 102.00K | 451.00K | ||
| Prepaid Expenses | 24.74M | 19.58M | 20.88M | 9.01M | 6.52M | 2.65M |
| Other Current Assets | 100.00K | |||||
| Total Current Assets | 1.08B | 894.23M | 738.46M | 486.48M | 431.17M | 200.16M |
| Property, Plant & Equipment | 4.85M | 3.65M | 3.44M | 3.34M | 2.94M | 2.06M |
| Other Long-Term Assets | 1.11M | 1.54M | 501.00K | 604.00K | 982.00K | 1.49M |
| Total Assets | 1.10B | 899.42M | 742.40M | 490.42M | 435.09M | 203.71M |
| Accounts Payable | 8.65M | 8.68M | 2.14M | 2.24M | 14.23M | 2.33M |
| Accrued Expenses | 54.24M | 60.89M | 44.93M | 23.16M | 18.11M | 10.40M |
| Current Portion of Leases | 722.00K | 753.00K | 513.00K | 843.00K | 613.00K | 520.00K |
| Current Unearned Revenue | 181.00K | 367.00K | 288.00K | 288.00K | 288.00K | 289.00K |
| Other Current Liabilities | 100.00K | 100.00K | 100.00K | |||
| Total Current Liabilities | 63.79M | 70.70M | 47.87M | 26.64M | 33.35M | 13.64M |
| Long-Term Debt | 242.16M | 49.94M | 20.58M | 20.20M | 4.64M | |
| Long-Term Leases | 1.85M | 1.90M | 989.00K | |||
| Long-Term Unearned Revenue | 573.00K | 861.00K | 1.15M | |||
| Other Long-Term Liabilities | 127.33M | 54.72M | 2.31M | 1.17M | 1.21M | |
| Total Liabilities | 435.14M | 177.25M | 70.76M | 48.40M | 40.03M | 15.99M |
| Common Stock | 1.13M | 1.02M | 810.00K | 540.00K | 414.00K | 239.00K |
| Additional Paid-In Capital | 2.13B | 1.93B | 1.48B | 960.54M | 741.07M | 412.10M |
| Retained Earnings | -1.57B | -1.34B | -995.86M | -725.91M | -488.17M | -358.30M |
| Comprehensive Income & Other | -1.15M | 447.00K | -10.00K | 338.00K | -390.00K | -157.00K |
| Total Common Equity | 564.07M | 590.11M | 482.75M | 235.51M | 252.92M | 53.88M |
| Shareholders' Equity | 662.10M | 722.17M | 671.64M | 442.02M | 395.06M | 187.72M |
| Total Liabilities & Equity | 1.10B | 899.42M | 742.40M | 490.42M | 435.09M | 203.71M |
| Total Debt | 244.73M | 52.59M | 21.09M | 22.04M | 5.26M | 520.00K |
| Net Cash (Debt) | 736.80M | 822.06M | 696.49M | 455.33M | 419.29M | 196.44M |
| Net Cash Per Share | 7.63 | 9.69 | 10.26 | 10.17 | 13.07 | 16.48 |
| Filing Date Shares Outstanding | 113.29M | 102.21M | 81.48M | 62.77M | 42.90M | 25.91M |
| Total Common Shares Outstanding | 113.24M | 101.83M | 80.99M | 53.99M | 41.31M | 23.92M |
| Working Capital | 1.02B | 823.54M | 690.59M | 459.84M | 397.82M | 186.53M |
| Book Value Per Share | 4.98 | 5.80 | 5.96 | 4.36 | 6.12 | 2.25 |
| Tangible Book Value | 554.07M | 590.11M | 482.75M | 235.51M | 252.92M | 53.88M |
| Tangible Book Value Per Share | 4.89 | 5.80 | 5.96 | 4.36 | 6.12 | 2.25 |
| Machinery | 2.17M | 2.25M | 2.05M | 2.22M | 1.40M | |
| Leasehold Improvements | 271.00K | 254.00K | 670.00K | 1.11M | 749.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -386.97M | -342.60M | -269.95M | -237.73M | -129.87M | -79.41M |
| Depreciation & Amortization | 468.00K | 460.00K | 540.00K | 522.00K | 255.00K | 120.00K |
| Loss (Gain) From Sale of Assets | 77.00K | |||||
| Loss (Gain) From Sale of Investments | -6.19M | -6.76M | -15.65M | -11.49M | -210.00K | 961.00K |
| Stock-Based Compensation | 53.61M | 44.30M | 42.15M | 67.17M | 19.77M | 14.46M |
| Other Operating Activities | 7.95M | 5.17M | 997.00K | 6.79M | 264.00K | 7.49M |
| Change in Accounts Receivable | 349.00K | -451.00K | ||||
| Change in Accounts Payable | -408.00K | 6.56M | -73.00K | -12.04M | 11.52M | 1.66M |
| Change in Unearned Revenue | -288.00K | 636.00K | ||||
| Change in Other Net Operating Assets | -1.80M | 16.47M | 9.67M | 2.62M | 4.38M | -116.00K |
| Operating Cash Flow | -333.34M | -276.39M | -232.32M | -184.17M | -93.84M | -54.58M |
| Capital Expenditures | -1.70M | -495.00K | -511.00K | -898.00K | -797.00K | -338.00K |
| Sale of Property, Plant & Equipment | 79.00K | |||||
| Investment in Securities | -365.54M | -37.07M | -228.14M | -93.35M | -114.33M | -74.03M |
| Investing Cash Flow | -367.24M | -37.56M | -228.65M | -94.25M | -115.13M | -74.29M |
| Long-Term Debt Issued | 28.88M | 15.00M | 5.00M | |||
| Total Debt Issued | 278.88M | 28.88M | 15.00M | 5.00M | ||
| Net Debt Issued (Repaid) | 224.18M | 28.88M | 15.00M | 5.00M | ||
| Issuance of Common Stock | 508.76M | 366.99M | 459.68M | 146.79M | 295.75M | 116.59M |
| Other Financing Activities | 15.31M | 30.88M | -26.94M | -12.31M | -22.51M | -8.28M |
| Financing Cash Flow | 748.24M | 426.74M | 457.74M | 225.67M | 322.24M | 125.28M |
| Net Cash Flow | 47.66M | 112.79M | -3.23M | -52.75M | 113.28M | -3.60M |
| Free Cash Flow | -335.04M | -276.89M | -232.83M | -185.07M | -94.64M | -54.92M |
| Free Cash Flow Margin | -471.04% | -390.81% | -77,096.03% | -58,938.85% | -5,340.58% | -1,853.49% |
| Free Cash Flow Per Share | -3.47 | -3.27 | -3.43 | -4.13 | -2.95 | -4.61 |
| Levered Free Cash Flow | -275.50M | -162.07M | -136.29M | -102.50M | -48.83M | -33.91M |
| Unlevered Free Cash Flow | -265.74M | -158.98M | -134.92M | -101.66M | -48.52M | -33.91M |
| Cash Interest Paid | 3.47M | 2.15M | 1.82M | 886.00K | 293.00K | |
| Change in Working Capital | -2.20M | 23.03M | 9.60M | -9.43M | 15.96M | 1.72M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.87B | 2.97B | 1.52B | 1.15B | 1.18B | 429.45M |
| Enterprise Value | 2.13B | 2.69B | 977.43M | 989.34M | 892.47M | 378.63M |
| Last Close Price | 25.30 | 31.12 | 19.17 | 21.78 | 29.21 | 19.77 |
| PS Ratio | 40.30 | 41.92 | 5,028.17 | 3,647.53 | 663.46 | 144.94 |
| PB Ratio | 5.08 | 4.11 | 2.26 | 2.59 | 2.98 | 2.29 |
| P/TBV Ratio | 5.17 | 5.03 | 3.15 | 4.86 | 4.65 | 7.97 |
| EV/Sales Ratio | 29.94 | 38.00 | 3,236.51 | 3,150.76 | 503.65 | 127.79 |
| Debt / Equity Ratio | 0.37 | 0.07 | 0.03 | 0.05 | 0.01 | 0.00 |
| Net Debt / Equity Ratio | -1.11 | -1.14 | -1.04 | -1.03 | -1.06 | -1.05 |
| Net Debt / EBITDA Ratio | 1.82 | 2.27 | 2.33 | 1.79 | 3.13 | 2.47 |
| Net Debt / FCF Ratio | 2.20 | 2.97 | 2.99 | 2.46 | 4.43 | 3.58 |
| Asset Turnover | 0.09 | 0.09 | 0.00 | 0.00 | 0.01 | 0.02 |
| Quick Ratio | 16.56 | 12.37 | 14.99 | 17.93 | 12.73 | 14.48 |
| Current Ratio | 16.95 | 12.65 | 15.43 | 18.27 | 12.93 | 14.68 |
| Return on Equity (ROE) | -65.74% | -49.16% | -48.48% | -56.80% | -44.57% | -51.61% |
| Return on Assets (ROA) | -30.16% | -27.67% | -30.32% | -34.37% | -26.28% | -29.75% |
| Return on Capital Employed (ROCE) | -39.20% | -43.90% | -43.10% | -54.90% | -33.40% | -41.90% |
| Earnings Yield | -13.67% | -11.54% | -17.78% | -20.76% | -11.05% | -18.49% |
| FCF Yield | -11.69% | -9.32% | -15.33% | -16.16% | -8.05% | -12.79% |
| Buyback Yield / Dilution | -24.83% | -24.92% | -51.68% | -39.48% | -169.22% | -235.07% |